SETBP1 mutations as a biomarker for myelodysplasia /myeloproliferative neoplasm overlap syndrome
Abstract Myelodysplasia (MDS) /myeloproliferative neoplasm (MPN) overlap syndrome has been described since the 2001 WHO classification as disorders that have both proliferative and dysplastic changes simultaneously. Specific disorders include chronic myelomonocytic leukemia (CMML), juvenile myelomon...
Saved in:
Main Authors: | Katherine Linder (Author), Chaitanya Iragavarapu (Author), Delong Liu (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2017-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms
by: Amandeep Aujla, et al.
Published: (2018) -
Novel SETBP1 mutation in a chinese family with intellectual disability
by: Le Wang, et al.
Published: (2023) -
Targeted therapies for myeloproliferative neoplasms
by: Bing Li, et al.
Published: (2019) -
The Hematopoietic Niche in Myeloproliferative Neoplasms
by: Annette H. Schmitt-Graeff, et al.
Published: (2015) -
SETBP-1 mutations favor transformation to AML in PTPN-11 positive JMML
by: Ravi Kumar Majhi, et al.
Published: (2024)